OCS
Oculis Holding AGNASDAQHealthcare$26.63-1.48%ClosedMarket Cap: $1.52B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
6.00
P/S
2384.61
EV/EBITDA
-11.78
DCF Value
$1.87
FCF Yield
-5.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
-2858.1%
Operating Margin
-16254.4%
Net Margin
-19598.9%
ROE
-62.5%
ROA
-41.8%
ROIC
-40.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-20.9M | $-23.3M | $-0.42 | — |
| FY 2025 | $0.00 | NaN% | $-79.1M | $-94.5M | $-1.81 | — |
| Q3 2025 | $243.0K | 100.0% | $-20.3M | $-16.9M | $-0.32 | — |
| Q2 2025 | $261.0K | -5612.3% | $-20.8M | $-25.4M | $-0.49 | — |
| Q1 2025 | $0.00 | NaN% | $-20.0M | $-33.2M | $-0.69 | — |
| Q4 2024 | $0.00 | NaN% | $-17.3M | $-28.7M | $-0.69 | — |
| FY 2024 | $686.0K | -7492.3% | $-73.2M | $-85.8M | $-2.12 | — |
| Q3 2024 | $0.00 | NaN% | $-18.1M | $-20.2M | $-0.48 | — |
| Q2 2024 | $0.00 | NaN% | $-22.5M | $-20.8M | $-0.51 | — |
| Q1 2024 | $0.00 | NaN% | $-15.3M | $-16.1M | $-0.44 | — |
| Q4 2023 | $0.00 | NaN% | $-12.2M | $-12.5M | $-0.34 | — |
| FY 2023 | $0.00 | NaN% | $-80.7M | $-88.8M | $-2.97 | — |